Eagle Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-36,042	Closed	-$2.23M	–	563
2023 Q4	$2.23M	Sell	36,042 -1,659	-4%	-$87.1K	0.01%	443
2023 Q3	$1.73M	Sell	37,701 -31,888	-46%	-$1.74M	0.01%	447
2023 Q2	$4M	Sell	69,589 -237,181	-77%	-$10.5M	0.02%	380
2023 Q1	$11.5M	Buy	306,770 +5,897	+2%	+$193K	0.07%	230
2022 Q4	$8.48M	Sell	300,873 -9,382	-3%	-$272K	0.05%	261
2022 Q3	$8.72M	Buy	310,255 +82,796	+36%	+$2.7M	0.06%	254
2022 Q2	$7.91M	Buy	227,459 +50,120	+28%	+$1.79M	0.05%	281
2022 Q1	$6.37M	Sell	177,339 -74,277	-30%	-$2.11M	0.03%	353
2021 Q4	$5.82M	Sell	251,616 -33,002	-12%	-$675K	0.03%	387
2021 Q3	$5.41M	Sell	284,618 -19,856	-7%	-$389K	0.02%	391
2021 Q2	$6.14M	Sell	304,474 -5,985	-2%	-$113K	0.03%	391
2021 Q1	$5.62M	Sell	310,459 -1,964	-0.6%	-$36.5K	0.02%	399
2020 Q4	$6.28M	Buy	312,423 +28,179	+10%	+$548K	0.04%	361
2020 Q3	$5.29M	Sell	284,244 -16,974	-6%	-$342K	0.03%	358
2020 Q2	$6.66M	Sell	301,218 -16,770	-5%	-$307K	0.04%	336
2020 Q1	$4.72M	Buy	317,988 +33,752	+12%	+$587K	0.03%	367
2019 Q4	$5.48M	Buy	+284,236	New	+$5.45M	0.03%	396